Holen Sie sich die Stockscreener-App
37.06
2.27%
-0.86
Handel nachbörslich:
38.25
1.19
+3.21%
Schlusskurs vom Vortag:
$37.92
Offen:
$37.6
24-Stunden-Volumen:
1.18M
Relative Volume:
0.49
Marktkapitalisierung:
$2.81B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-275.16M
KGV:
-9.527
EPS:
-3.89
Netto-Cashflow:
$-221.15M
1W Leistung:
-1.07%
1M Leistung:
-25.72%
6M Leistung:
+21.55%
1J Leistung:
-7.58%
1-Tages-Spanne:
$36.52
$38.28
1-Wochen-Bereich:
$36.08
$39.03
52-Wochen-Spanne:
$28.21
$62.00
Springworks Therapeutics Inc Stock (SWTX) Company Profile
Firmenname
Springworks Therapeutics Inc
Sektor
Branche
Telefon
203-883-9490
Adresse
100 WASHINGTON BOULEVARD, STAMFORD, CT
Vergleichen Sie SWTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
37.06 | 2.81B | 0 | -275.16M | -221.15M | -3.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-20 | Eingeleitet | Evercore ISI | Outperform |
| 2024-02-05 | Eingeleitet | Guggenheim | Buy |
| 2022-12-01 | Eingeleitet | BofA Securities | Buy |
| 2021-01-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-05 | Eingeleitet | Barclays | Overweight |
| 2020-03-19 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-01-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-10-08 | Eingeleitet | Cowen | Outperform |
| 2019-10-08 | Eingeleitet | Goldman | Buy |
| 2019-10-08 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Springworks Therapeutics Inc Aktie (SWTX) Neueste Nachrichten
How a scrapped Pfizer drug became a winner for SpringWorks - PharmaVoice
Wells Fargo & Company MN Has $5.71 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Purchased by Invesco Ltd. - MarketBeat
Russell Investments Group Ltd. Has $4.08 Million Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Alliancebernstein L.P. Decreases Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
JPMorgan Chase & Co. Sells 27,117 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Stock Traders Buy Large Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
(SWTX) Investment Report - news.stocktradersdaily.com
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
BofA Adjusts Price Target on Springworks Therapeutics to $84 From $87, Keeps Buy Rating - marketscreener.com
SpringWorks Therapeutics (SWTX) Price Target Lowered by Bank of America | SWTX Stock News - GuruFocus
Fmr LLC Raises Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Norges Bank Buys New Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 7.1%Time to Sell? - MarketBeat
Here's Why We're Not At All Concerned With SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation - Yahoo Finance
Massachusetts Financial Services Co. MA Sells 50,547 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Stock Holdings Boosted by Finepoint Capital LP - MarketBeat
Vanguard Group Inc. Increases Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Schroder Investment Management Group Has $6.11 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
KLP Kapitalforvaltning AS Makes New $455,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
2seventy, TG, Springworks lead cancer index among Q1 market falls - BioWorld MedTech
SpringWorks Therapeutics (NASDAQ:SWTX) Trading 5.5% HigherHere's Why - MarketBeat
NEOS Investment Management LLC Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Pictet Asset Management Holding SA Has $86.40 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Stock Surge: An Investor’s Dilemma - timothysykes.com
SpringWorks Therapeutics Enters Oversold Territory (SWTX) - Nasdaq
BIT Capital GmbH Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Segall Bryant & Hamill LLC Has $6.99 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Cibc World Markets Corp Acquires New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Swiss National Bank Has $4.22 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 2.5%Time to Sell? - MarketBeat
SpringWorks Therapeutics Target of Unusually Large Options Trading (NASDAQ:SWTX) - MarketBeat
Finanzdaten der Springworks Therapeutics Inc-Aktie (SWTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):